Mahasabha firm on Veerashaiva-Lingayat dharma

Bengaluru,  Jul 21: The salaries of doctors under the National Health Mission (NHM) has been hiked to Rs 45,000 in Karnataka, according to Medical Education Minister Dr K Sudhakar.

Addressing the media on Monday, Dr Sudhakar said that the state government will bear the cost of the hike in salaries of the doctors and added that ASHA workers too will get a hike in their pay soon.

Regarding the COVID-19 management in the state, he further said that testing will be increased in the containment zones.

During a meeting chaired by Chief Minister BS Yediyurappa, the Education Minister said that it had been decided that booth level committees will conduct door to door survey for early detection of influenza-like illness (ILI) and severe acute respiratory infections (SARI), and vulnerable persons.

He also implored private hospitals to admit and treat COVID-19 patients and asked them to not be hesitant in admitting pregnant women.

Karnataka on Monday reported 3,648 COVID-19 cases taking the tally to 67,420, informed the state health department.

According to a bulletin issued by the department, the state recorded 72 more deaths due to COVID-19 with the toll at 1,403 while six patients who tested positive for the infection have died due to non-COVID causes, as of Monday. There are 42,216 active cases in the state.

Mangaluru, Jul 22: As many as 184 people from Karnataka stranded in UAE arrived at Mangalore International Airport.

According to sources, the chartered flight, which landed on Tuesday night, was arranged by the UAE Karnataka Cultural Foundation and Beary Cultural Foundation for Kannadigas who had been stranded following the lockdown and also those who had lost their employment.

A team of officials with Puttur Assistant Commissioner Yathish Ullal and Horticulture Department Assistant Director Praveen who were in charge of quarantine facilities for international passengers verified the documents and sent them for institutional quarantine.

Of the 184 passengers, 141 had remained quarantined in Mangaluru while 42 left for Udupi and one to Honnavara in Uttara Kannada, said sources.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.